Evaluation of hypertension and its related factors in adults in Torbat-e Heydarieh, Iran

Authors
Malihe Mohammadi
Seyedeh Solmaz Moosavi
Department of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran
Abstract
Introduction

Hypertension is the major risk factor for cardiovascular disease. The purpose of this study was to quantify the prevalence of hypertension in adults of Torbat-e Heydarieh City

Materials and Methods

this cross-sectional study was performed on 278 volunteers over the age 18, who referred Torbat-e Heydarieh Health centers. Demographic information was collected by a questionnaire and then blood pressure was measured by standard method, and those with high blood pressure were re-measured two weeks later. The SPSS software and Chi square test were used for data analysis. P<0.05 was considered statistical significance level

Results

the prevalence of hypertension was 23.03% and no statically differences were observed between men and women (p= 0.069). 32.8% of participants with hypertension were unaware of their disease and 48.4% of them using antihypertensive medication. There is a significant correlation between hypertension prevalence and aging, urbanization (p=0.008), low physical activity (p=0.047), low level of education (p=0.046) and family history of hypertension (p=0.003). But there was no significant association between high blood pressure and smoking (p=0.101), alcohol consumption (p=0.433) and diet (P>0.05)

Conclusion

The prevalence of hypertension is high in the study community, especially in the urban community. On the other hand, the rate of awareness and treatment is low. Therefore, the intervention of health organizations in order to educate, prevent, change lifestyles and monitor people from an early age is essential.
Keywords
Hypertension
Prevalence
Knowledge
risk factors
1. Guo F, He D, Zhang W, Grace Walton R. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012; 60 (7):599-606. DOI: 10.1016/j.jacc.2012.04.026
2. Singh RB, Suh IL, Singh VP, Chaithiraphan S, Laothavorn P, Sy RG, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000; 14 (10-11):749-63. DOI: 10.1038/sj.jhh.1001057
3. Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013; 3 (8):e003423. DOI: 10.1136/bmjopen-2013-003423
4. Haghdoost AA, Sadeghirad B, Rezazadehkermani M. Epidemiology and heterogeneity of hypertension in Iran: a systematic review. Arch Iran Med. 2008; 11(4):444-52. PMID: 18588378
5. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009; 27 (5):963-75. DOI: 10.1097/hjh.0b013e3283282f65
6. Zinat Motlagh SF, Chaman R, Ghafari SR, Parisay Z, Golabi MR, Eslami AA, et al. Knowledge, Treatment, Control, and Risk Factors for Hypertension among Adults in Southern Iran. Int J Hypertens. 2015; 2015: 897070. DOI: 10.1155/2015/897070
7. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004; 22 (1):11-9. DOI: 10.1097/00004872-200401000-00003
8. Azizi F, Ghanbarian A, Madjid M, Rahmani M. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000. J Hum Hypertens. 2002; 16 (5):305-12. DOI: 10.1038/sj.jhh.1001399
9. Yousefinejad V, Shahghaibi SH, Arabzade M, Soori M, Darvishi N. The prevalence of high blood pressure in blood donors and the relevant factors in Sanandaj Blood Transfusion Center in 1384. SJIBTO 2007; 3 (5):413-418. [Persian] http://bloodjournal.ir/article-1-138-en.pdf
10. Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens. 2013; 31 (7):1364-71. DOI: 10.1097/HJH.0b013e3283613053
11. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455):217-23. DOI: 10.1016/S0140-6736(05)17741-1
12. Sadeghi M, Roohafza HR, Kelishadi R. Blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme. Med J Malaysia. 2004; 59(4):460-7. PMID: 15779578
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42 (6):1206-52. DOI: 10.1161/01.HYP.0000107251.49515.c2
14. Jafari Oori M, Mohammadi F, Norozi K, Fallahi-Khoshknab M, Ebadi E, Ghanei Gheshlagh R. Prevalence of HTN in Iran: Meta-analysis of Published Studies in 2004-2018. Curr Hypertens Rev. 2019; 15(2): 113–122. DOI: 10.2174/1573402115666190118142818
15. Delavari A, Horri N, Alikhani S, Gouya M, Mahdavi A, Hosseini S, et al . Prevalence of Hypertension in Iranian Urban and Rural Populations Aged over 20 years in 2004. J Mazandaran Univ Med Sci. 2007; 17 (58):79-86 [Persian]
16. Marteau JB, Zaiou M, Siest G, Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens. 2005; 23(12): 2127-2143. DOI: 10.1097/01.hjh.0000186024.12364.2e
17. Dabaghmanesh MH, Mostafavi H, Zare N. Blood pressure levels, risk factor and hypertension control status in adult population of Shiraz. Hormozgan Med J. 2007; 11(1):e89106. [Persian] https://sites.kowsarpub.com/hmj/articles/89106.html
18. Khajedaluee M, Hassannia T, Rezaee A, Ziadi M, Dadgarmoghaddam M. The prevalence of hypertension and its relationship with demographic factors, biochemical, and anthropometric indicators: A population-based study. ARYA Atheroscler. 2016; 12(6): 259–265. http://arya.mui.ac.ir/index.php/arya/article/view/1345
19. Katibeh M, Sanjari Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H. Hypertension and associated factors in the Islamic Republic of Iran: a population‐based study. East Mediterr Health J. 2020; 26(3): 304-314. https://doi.org/10.26719/emhj.19.042
20. Meraci M, Feizi A, Bagher Nejad M. Investigating the Prevalence of High Blood Pressure, Type 2 Diabetes Mellitus and Related Risk Factors According to a Large General Study in Isfahan- Using Multivariate Logistic Regression Model. J Health Syst Res. 2012; 8(2): 193-203. [Persian] https://www.sid.ir/en/journal/ViewPaper.aspx?id=337904
21. Shariatpanahi SP, Habibi D, Rafiei M, Ghandi Y, Anvari M. Determination of Relations between Systolic Blood Pressure and Heart Attack in Patients with Type 2 Diabetes with Association Rules. AMUJ. 2018; 20(129): 44-50. [Persian] https://www.sid.ir/en/journal/ViewPaper.aspx?id=573703
22. Sadghi M, Roohafza HR, Asgary S, Sadry GH, Bahonar A, Amani A, et al. Prevalence of high blood pressure and its relation with cardiovascular risk factors. Journal of Inflammatory Diseases. 2003; 7(2): 46-52. [Persian] http://journal.qums.ac.ir/article-1-241-en.html
23. Mojahedi MJ, Hami M, Shakeri MT, Hasani MH, Ahadi M. he Prevalence and related risk factors of hypertension in young adults in Mashhad Hypertension in young adults. Medical Journal of Mashhad. 2015; 58(5): 252-257. [Persian] http://mjms.mums.ac.ir/article_4742.html
24. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-middle, and low-income countries. JAMA. 2013; 310 (9): 959-968. DOI: 10.1001/jama.2013.184182
25. Pearson TA. Cardiovascular disease in developing countries: myths, realities, and opportunities. Cardiovasc Drugs Ther. 1999; 13(2): 95-104. DOI: 10.1023/a:1007727924276